| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.4 |